STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells

Abstract

Genetic analysis of human inborn errors of immunity has defined the contribution of specific cell populations and molecular pathways in the host defense against infection. The STAT family of transcription factors orchestrate hematopoietic cell differentiation. Patients with de novo activating mutations of STAT3 present with multiorgan autoimmunity, lymphoproliferation, and recurrent infections. We conducted a detailed characterization of the blood monocyte and dendritic cell (DC) subsets in patients with gain-of-function (GOF) mutations across the gene. We found a selective deficiency in circulating nonclassical CD16+ and intermediate CD16+CD14+ monocytes and a significant increase in the percentage of classical CD14+ monocytes. This suggests a role for STAT3 in the transition of classical CD14+ monocytes into the CD16+ nonclassical subset. Developmentally, ex vivo–isolated STAT3GOF CD14+ monocytes fail to differentiate into CD1a+ monocyte-derived DCs. Moreover, patients with STAT3GOF mutations display reduced circulating CD34+ hematopoietic progenitors and frequency of myeloid DCs. Specifically, we observed a reduction in the CD141+ DC population, with no difference in the frequencies of CD1c+ and plasmacytoid DCs. CD34+ hematopoietic progenitor cells from patients were found to differentiate into CD1c+ DCs, but failed to differentiate into CD141+ DCs indicating an intrinsic role for STAT3 in this process. STAT3GOF-differentiated DCs produced lower amounts of CCL22 than healthy DCs, which could further explain some of the patient pathological phenotypes. Thus, our findings provide evidence that, in humans, STAT3 serves to regulate development and differentiation of nonclassical CD16+ monocytes and a subset of myeloid DCs.

CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

“…High concentrations of IL-6 (250 ng/ml) skewed the development from DC1 toward DC2 [SIRP-α + ; fig. S13H (dark blue)] ( 51 , 52 ); however, low IL-6 concentrations (below 20 ng/ml) increased the expression of CD5 on both of these DC subsets [Fig. 6, H and I, and S13H (light blue)].…”

Single-cell RNA-seq reveals alterations in peripheralCX3CR1and nonclassical monocytes in familial tauopathy

“…For example, a putative DC subpopulation, identified transcriptomically and originally termed DC4 [92], is now considered to probably represent a subset of NC monocytes rather than DCs [46,93,94]. In addition, pathogenic variants in STAT3 have revealed this gene's role in regulating the production of both NC monocytes and the less-abundant cDC population, cDC1 [95]. Although we could detect the rare cDC1 population in our dataset, it became apparent only upon myeloid cell re-clustering (myeloid subcluster 7, marked by CLEC9A expression), and these cells were too sparse to enable us to accurately gauge their abundance or use for normalization purposes.…”

A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice

“…The STAT3 pathway is activated downstream of numerous cytokines and growth factors, and it has been broadly implicated in both innate and adaptive immune pathways ( 50 ). Studies have demonstrated that germline STAT3 GOF variants lead to alterations in human monocyte and DC populations ( 51 ). Changes in relevant antigen presenting cell phenotype and chemokine expression may have an impact on local pTreg induction and/or localization ( 34 , 52 ).…”